Biotech CEO Sisterhood

Biotech CEO Sisterhood: Kate Haviland discusses the success factors that led to the $9B+ acquisition of Blueprint Medicines, and the trend of biotech companies taking commercial assets further


Listen Later

Interviewed by Sisterhood editorial board member Daphne Zohar, Kate Haviland talks about the numerous programs that Blueprint created, the rationale behind key go/no-go and partnering decisions, and how she feels about the biotech sector today.

...more
View all episodesView all episodes
Download on the App Store

Biotech CEO SisterhoodBy BiotechTV

  • 5
  • 5
  • 5
  • 5
  • 5

5

3 ratings


More shows like Biotech CEO Sisterhood

View all
The Studio at Kendall Square by BiotechTV

The Studio at Kendall Square

0 Listeners

Off-Target Effects with Matt Gline by BiotechTV

Off-Target Effects with Matt Gline

4 Listeners

BioVenture VoiCes with Chris Garabedian by BiotechTV

BioVenture VoiCes with Chris Garabedian

5 Listeners

BiotechTV - News by BiotechTV

BiotechTV - News

7 Listeners